Tafalgie Therapeutics selected as a finalist for the regional EY Entrepreneur of the Year 2024 award
On Thursday, September 19, 2024, Tafalgie Therapeutics was selected as a finalist for the EY Entrepreneur of the Year 2024 award in the Start-up category for the South-East region of France. This recognition came during the regional finals of the prestigious EY competition, organized in partnership with Edmond de Rothschild, Samsic, Steelcase, and Verlingue, with the support of Bpifrance. The ceremony took place at the Regional Council headquarters in Marseille.
Now in its 32nd year, the EY Entrepreneur of the Year award is a prestigious program organized by Ernst & Young, a global leader in auditing, financial, and legal advisory services. The award honors entrepreneurial leaders who drive growing businesses while balancing responsibility and sustainable economic models. The selection criteria for the 2024 cohort were particularly demanding, with an independent jury of esteemed professionals choosing the final laureates from nearly 270 exceptional candidates across eight regions. Regional ceremonies were held from September to October 2024, and the event will culminate in a national ceremony featuring all regional winners.
In addition to the Entrepreneur of the Year award, four other special categories were recognized: Family Businesses, Startups, Scale-ups, and Social Impact.
Tafalgie Therapeutics stood out among 270 engaged companies that are tackling societal challenges and offering highly innovative solutions with significant potential for large-scale deployment.
This recognition is a source of great pride for Eric Schettini, Tafalgie’s CEO :